Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing

This document is a Response to Comments regarding the MolDX: Melanoma Risk Stratification Molecular Testing Local Coverage Determination (LCD L37725) and does not itself state coverage criteria. The notice period begins 05/19/2022 and the LCD becomes effective 07/03/2022; consult LCD L37725 for the detailed coverage, exclusions, and documentation requirements referenced by these responses to comments. Other details and specific clinical criteria are not provided in this document and require review of L37725 and associated guidance.